首页> 外文期刊>International journal of biological sciences >Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
【24h】

Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages

机译:褪黑素治疗的肝癌细胞的外泌体通过巨噬细胞中的STAT3途径改变免疫抑制状态。

获取原文
           

摘要

Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1β, and TNF-α in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro . PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status.
机译:免疫抑制是肿瘤侵袭和转移进展的重要因素。褪黑激素是一种众所周知的激素,具有一定的细胞毒性和免疫调节作用,以抑制肿瘤功能。外泌体是由多种细胞释放的小膜囊泡,其中包含不同的大分子,例如mRNA和microRNA(miRNA),以及可以介导细胞之间通讯的蛋白质。肿瘤来源的外泌体可能引起免疫抑制,但是,褪黑激素是否可以通过改变肿瘤来源的外泌体的功能来减弱免疫抑制状态尚不明确。在本研究中,我们评估了肝细胞癌性外泌体(Exo-con)和0.1 mM褪黑素(Exo-MT)处理的肝细胞衍生的外泌体对炎症因子和程序性死亡配体1(PD- L1),分别将Exo-con和Exo-MT与从THP-1细胞或RAW264.7细胞分化出来的巨噬细胞共培养。我们的体外结果表明,Exo-MT可通过流式细胞仪和免疫荧光分析来下调巨噬细胞上PD-L1的表达,而Exo-con则可上调PD-L1的表达。另外,Exo-con上调巨噬细胞中IL-6,IL-10,IL-1β和TNF-α等细胞因子的分泌。因此,Exo-MT可以减弱这些炎症细胞因子的高表达。此外,体内实验证实了体外发现的结果。与Exo-con组相比,Exo-MT组的PD-L1表达和细胞因子分泌较低。为了确定一种特定的机制,我们的研究表明,与Exo-con组相比,Exo-MT可以降低STAT3激活。总之,我们发现褪黑素治疗的肝癌细胞中的外泌体通过巨噬细胞中的STAT3途径改变了免疫抑制状态。我们的研究可能为研究褪黑激素调节免疫抑制状态的机制提供一条新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号